Myristylation of gag protein in human T-cell leukemia virus type-I and type-II

Area of Science:

• Biochemistry
• Virology
• Molecular Biology

Background:

• Human T-lymphotropic virus (HTLV) is associated with various diseases.
• Understanding the post-translational modifications of HTLV proteins is crucial for comprehending viral replication and pathogenesis.
• Myristoylation is a lipid modification that can affect protein localization, stability, and function.

Purpose of the Study:

• To investigate the myristoylation status of Gag proteins from HTLV-I and HTLV-II.
• To determine if the p28 protein, which cross-reacts with anti-p19gag antibodies, is myristylated in different HTLV infection contexts.

Main Methods:

• Analysis of myristoylation of HTLV-I and HTLV-II Gag proteins using biochemical assays.
• Immunological detection of myristylated proteins in infected cell lines (MT-2, HUT102 for HTLV-I; Mo, Ton1 for HTLV-II) using specific monoclonal antibodies.

Main Results:

• The p19gag protein of HTLV-I and the p23gag protein of HTLV-II were confirmed to be myristylated.
• The p28 protein, immunologically similar to HTLV-I p19gag, was found to be myristylated in HTLV-I infected cell lines (MT-2, HUT102).
• No myristylated p28 was detected in HTLV-II infected cell lines (Mo, Ton1).

Conclusions:

• Myristoylation is a common modification for HTLV Gag proteins.
• The p28 protein's myristoylation is specific to HTLV-I infection, suggesting distinct roles or regulation compared to HTLV-II.
• These findings contribute to understanding the molecular mechanisms of HTLV replication and potential therapeutic targets.